[初级保健中的慢性肾病管理:新的初级保健实用指南]。

Q4 Medicine
Anna Silvano, Paolo Di Taranto, Sarah Fiorentini, Sophie De Seigneux, Arun Senchyna
{"title":"[初级保健中的慢性肾病管理:新的初级保健实用指南]。","authors":"Anna Silvano, Paolo Di Taranto, Sarah Fiorentini, Sophie De Seigneux, Arun Senchyna","doi":"10.53738/REVMED.2024.20.888.1687","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic kidney disease is often encountered in clinical practice, affecting between 8 and 16% of the world's population. Screening for CKD represents a major challenge for patients, given the increase in morbidity and mortality associated with the disease, as well as a public health issue in terms of slowing the progression to end-stage renal failure, which requires costly replacement treatments (dialysis and transplantation). The new KDIGO guidelines suggest aiming for optimal control of the cardiovascular risk factors associated with chronic kidney disease, in particular with the help of emerging treatments such as SGLT2 inhibitors. This article summarises the latest nephroprotection recommendations for primary care physicians.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Management of chronic kidney disease in primary care: New practical guidelines in primary care].\",\"authors\":\"Anna Silvano, Paolo Di Taranto, Sarah Fiorentini, Sophie De Seigneux, Arun Senchyna\",\"doi\":\"10.53738/REVMED.2024.20.888.1687\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Chronic kidney disease is often encountered in clinical practice, affecting between 8 and 16% of the world's population. Screening for CKD represents a major challenge for patients, given the increase in morbidity and mortality associated with the disease, as well as a public health issue in terms of slowing the progression to end-stage renal failure, which requires costly replacement treatments (dialysis and transplantation). The new KDIGO guidelines suggest aiming for optimal control of the cardiovascular risk factors associated with chronic kidney disease, in particular with the help of emerging treatments such as SGLT2 inhibitors. This article summarises the latest nephroprotection recommendations for primary care physicians.</p>\",\"PeriodicalId\":21286,\"journal\":{\"name\":\"Revue medicale suisse\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue medicale suisse\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53738/REVMED.2024.20.888.1687\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue medicale suisse","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53738/REVMED.2024.20.888.1687","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

慢性肾脏病是临床上经常遇到的疾病,影响着全球 8% 到 16% 的人口。筛查慢性肾脏病对患者来说是一项重大挑战,因为该病会增加发病率和死亡率,同时也是一个公共卫生问题,因为该病会导致肾功能衰竭发展到晚期,需要昂贵的替代治疗(透析和移植)。新的 KDIGO 指南建议以最佳方式控制与慢性肾病相关的心血管风险因素为目标,尤其是在 SGLT2 抑制剂等新兴治疗方法的帮助下。本文总结了针对初级保健医生的最新肾保护建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Management of chronic kidney disease in primary care: New practical guidelines in primary care].

Chronic kidney disease is often encountered in clinical practice, affecting between 8 and 16% of the world's population. Screening for CKD represents a major challenge for patients, given the increase in morbidity and mortality associated with the disease, as well as a public health issue in terms of slowing the progression to end-stage renal failure, which requires costly replacement treatments (dialysis and transplantation). The new KDIGO guidelines suggest aiming for optimal control of the cardiovascular risk factors associated with chronic kidney disease, in particular with the help of emerging treatments such as SGLT2 inhibitors. This article summarises the latest nephroprotection recommendations for primary care physicians.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revue medicale suisse
Revue medicale suisse Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
1210
期刊介绍: Destinée aux professionnels de santé, la plateforme revmed.ch regroupe la version électronique de la Revue Médicale Suisse et les applications de formation et d"aide à la prise de décision eRMS. La eRMS est le fruit d’une large collaboration entre institutions et praticiens de Suisse romande.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信